15.09.2015 • News

Ter Group Expands its Business in Italy

Effective Sept. 1, 2015, Ter Chemicals Distribution Group, based in Hamburg, Germany, transferred its Italian business with specialty chemicals into the recently founded company Ter Italia.

Oliver Zimmermann, CEO of Ter Chemicals Distribution Group, said: ”It was only a question of time to found a company in Italy as one of the major European markets and serve its highly attractive demand. Our new branch in Milan will further increase the market penetration of Ter Chemicals in Europe. Furthermore the established presence in Italy will strengthen our long-term relationships with strategic principals as well as attract new reliable and competent ones.”

Ivan Calcaterra, country manager at Ter Italia, commented: "From the outset Ter Italia S.r.l. can already count on a range of specialty chemicals of primary importance, which are supplied into our strategic customer industries. We will further develop our portfolio with focus on innovative raw materials and chemical specialties for sustainable development. Besides we are confident to successfully extend some of the present Ter Group’ partnerships to the Italian market. The technical education and competence in customers’ applications of Ter Italia’s sales team, together with an excellent logistics platform represent a cornerstone and important contribution towards fulfilling our targets: we aim to become the perfect supply partner for our clients: reliable, committed, accurate and on time. We are looking forward to the new challenge.”

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.